Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A "zinc finger pseudogene" describes a segment of DNA resembling the sequence of a zinc finger protein gene, but which lacks the ability to produce a functional protein product due to disabling mutations or incomplete coding sequences. Zinc finger proteins form a large superfamily of transcriptional regulators and DNA/RNA-binding proteins, characterized by one or more structural domains stabilized by zinc ions and characterized by specific cysteine and histidine residues[1][4][5][6]. However, a zinc finger pseudogene (such as ENSG00000266818) is an **inactivated or non-functional copy**, categorized as a pseudogene and thus not expected to take part in biological signaling, transcriptional regulation, or disease[3][6]. Context and rationale: - ENSG00000266818 maps to a region listed in Ensembl/HGNC as a **pseudogene**, not a protein-coding gene or a known modulator of human physiology. - **Zinc finger pseudogenes** might arise from gene duplication or retrotransposition events, after which they accumulate mutations that prevent expression of a functional protein[5][6]. - These loci are not *therapeutically actionable* nor involved in known drug mechanisms. - The name is generic, and many zinc finger pseudogenes exist throughout the human genome[3][6]. Note on nomenclature: - “Zinc finger pseudogene” is generic, and various locus-specific names (e.g., ZNF271P) may exist, but none of these correspond to active, targetable proteins[6]. If the intention was to refer to a functional **zinc finger protein** or a specific gene, further information or a corrected gene identifier would be needed. Otherwise, as written and for ENSG00000266818, this is a non-target pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger pseudogene.